SEC INSIDER TRANSACTIONS

GILEAD SCIENCES, INC. (GILD) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

GILD · GILEAD SCIENCES, INC.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 34 filings · fetched 2026-11-13T18:00:06Z

Recent reported activity

0purchase rows on this page

16sale rows on this page

110matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-06Filed 2026-11-09	Cain Wettan Keeley MOfficer · EVP Gen Counsel, Legal & Comp Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 07, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	3,399D	164.11	Direct	Form 4 ↗0002110603-26-000015
2026-11-05Filed 2026-11-06	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F3	M Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	9,810D	0	Direct	Form 4 ↗0001638643-26-000040
2026-11-05Filed 2026-11-06	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1	S Sale (market/private)Common Stock · Non-derivative	9,810D	175.17	Direct	Form 4 ↗0001638643-26-000040
2026-11-05Filed 2026-11-06	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	9,810A	72.34	Direct	Form 4 ↗0001638643-26-000040
2026-11-04Filed 2026-11-06	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F3	M Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	102,619D	0	Direct	Form 4 ↗0001638643-26-000040
2026-11-04Filed 2026-11-06	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	102,619D	175.1627	Direct	Form 4 ↗0001638643-26-000040
2026-11-04Filed 2026-11-06	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.35. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	102,619A	72.34	Direct	Form 4 ↗0001638643-26-000040
2026-11-02Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F7	S Sale (market/private)Common Stock · Non-derivative	2,000D	171.0627	Direct	Form 4 ↗0001638643-26-000038
2026-11-02Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F6	S Sale (market/private)Common Stock · Non-derivative	7,796D	170.3527	Direct	Form 4 ↗0001638643-26-000038
2026-11-02Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F5	S Sale (market/private)Common Stock · Non-derivative	1,904D	169.2733	Direct	Form 4 ↗0001638643-26-000038
2026-11-02Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F4	S Sale (market/private)Common Stock · Non-derivative	1,700D	168.1006	Direct	Form 4 ↗0001638643-26-000038
2026-11-02Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	1,600D	167.3999	Direct	Form 4 ↗0001638643-26-000038
2026-10-30Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F8	M Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative	15,881D	0	Direct	Form 4 ↗0001638643-26-000038
2026-10-30Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	15,881D	175.2456	Direct	Form 4 ↗0001638643-26-000038
2026-10-30Filed 2026-11-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $175.05 to $175.45. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $166.69 to $167.66. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F4 Sale prices for the transactions reported range from $167.72 to $168.68. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F5 Sale prices for the transactions reported range from $168.78 to $169.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F6 Sale prices for the transactions reported range from $169.83 to $170.82. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F7 Sale prices for the transactions reported range from $170.83 to $171.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F8 The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	15,881A	72.34	Direct	Form 4 ↗0001638643-26-000038
2026-10-15Filed 2026-10-16	Dickinson Andrew DOfficer · Chief Financial Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. References: F1	S Sale (market/private)Common Stock · Non-derivative	3,000D	156.22	Direct	Form 4 ↗0001310204-26-000031
2026-10-15Filed 2026-10-16	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. References: F1	S Sale (market/private)Common Stock · Non-derivative	3,000D	156.22	Direct	Form 4 ↗0001782135-26-000035
2026-10-01Filed 2026-10-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $147.21 to $148.205. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $148.23 to $149.13. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	3,000D	148.6265	Direct	Form 4 ↗0001638643-26-000035
2026-10-01Filed 2026-10-02	O'Day Daniel PatrickDirector · Officer · Chairman & CEO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026. F2 Sale prices for the transactions reported range from $147.21 to $148.205. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $148.23 to $149.13. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	12,000D	147.719	Direct	Form 4 ↗0001638643-26-000035
2026-09-22Filed 2026-09-23	Burkhart ErinOfficer · SVP, Controllership Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1, F2	M Exercise / conversionRestricted Stock Unit · Derivative	2,223D	—	Direct	Form 4 ↗0001927648-26-000005
2026-09-22Filed 2026-09-23	Burkhart ErinOfficer · SVP, Controllership Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. References:	F WithholdingCommon Stock · Non-derivative	768D	152.67	Direct	Form 4 ↗0001927648-26-000005
2026-09-22Filed 2026-09-23	Burkhart ErinOfficer · SVP, Controllership Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	2,223A	—	Direct	Form 4 ↗0001927648-26-000005
2026-09-15Filed 2026-09-16	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $143.16 to $144.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.26 to $144.775. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. References: F1	S Sale (market/private)Common Stock · Non-derivative	600D	145.29	Direct	Form 4 ↗0001782135-26-000033
2026-09-15Filed 2026-09-16	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $143.16 to $144.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.26 to $144.775. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. References: F1, F3	S Sale (market/private)Common Stock · Non-derivative	800D	144.4569	Direct	Form 4 ↗0001782135-26-000033
2026-09-15Filed 2026-09-16	Mercier JohannaOfficer · Chief Comm & Corp Aff Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 Sale prices for the transactions reported range from $143.16 to $144.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. F3 Sale prices for the transactions reported range from $144.26 to $144.775. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. References: F1, F2	S Sale (market/private)Common Stock · Non-derivative	1,600D	143.6917	Direct	Form 4 ↗0001782135-26-000033

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.